An FSH test measures follicle-stimulating hormone, the pituitary signal that tells ovaries to ripen an egg and testicles to make sperm. It sits at the center of fertility workups, missing-period investigations, early menopause questions, and male infertility evaluations. The twist most people miss: FSH is a message, not a motor. The number tells you how loudly the brain is shouting at the ovaries or testes, which is exactly why a high result means the opposite of what many first assume.
Key takeaways
- FSH comes from the pituitary gland, so the test reads the brain’s side of the conversation with your ovaries or testes, almost always alongside LH and estradiol.
- High FSH usually means the gonads are underperforming and the pituitary is turning up the volume: menopause territory in women, testicular failure territory in men.
- In menstruating women, levels swing with the cycle, so baseline draws happen on day 2 to 4. In perimenopause they swing month to month, which is why one result cannot diagnose or rule out the transition.
- Hormonal birth control suppresses FSH by design. A result taken on the pill mostly measures the pill.
- A normal FSH does not certify fertility, and treatments do not target FSH itself; it is a gauge, not the engine.
What an FSH test measures
Follicle-stimulating hormone is one of the two reproductive messengers the pituitary gland releases, the other being luteinizing hormone (LH). Per MedlinePlus, FSH in women drives the growth of ovarian follicles, the small sacs that each contain an egg, and in men it supports sperm production in the testicles. The hypothalamus tells the pituitary what to do, the pituitary releases FSH and LH, and the ovaries or testes answer back with estrogen or testosterone, which then feed back to quiet the brain’s signal. One blood draw from your arm captures your FSH level at that moment.
Understanding that loop is the whole trick to this test. The pituitary behaves like a thermostat: when the ovaries or testes respond well, feedback hormones keep FSH modest. When they respond poorly, the feedback fades and the pituitary raises its voice. So FSH is best read as the brain’s running commentary on how the reproductive glands are performing. A loud signal means the glands are struggling to answer. A quiet signal with struggling glands means the problem sits upstream, in the pituitary or hypothalamus. That is why this test almost never travels alone: paired with LH and estradiol in women, or testosterone in men, it locates the problem rather than just naming one.
FSH moves with your cycle and your decade
In a menstruating woman, FSH follows the menstrual cycle: modest in the early follicular days, a sharp mid-cycle spike alongside the LH surge that triggers ovulation, then lower in the second half. That rhythm is why baseline measurement is standardized to day 2 to 4 of the cycle, counted from the first day of full flow, usually with estradiol drawn at the same time. The estradiol matters because a quietly high early-cycle estradiol can suppress FSH into looking deceptively normal, one of the classic traps in reading this hormone.
Across decades, FSH drifts upward as the ovarian follicle supply declines, then climbs steeply through the menopause transition and stays high afterward. But the climb is not a smooth staircase. In perimenopause, ovaries respond some months and not others, so FSH can read postmenopausal in March and reproductive-age in May. Both results are real. Neither settles anything alone, which becomes important below.
In men, FSH holds comparatively steady day to day, which makes interpretation simpler: no cycle math, just the level read against testosterone, LH, and, in fertility evaluations, a semen analysis.
Who needs this test
Women in a fertility workup. FSH with estradiol on day 2 to 4 is a standard early step when conceiving is taking longer than expected. It helps gauge how hard the brain is working to recruit a follicle each month. Worth knowing: for estimating egg supply, the AMH test has largely taken over as the first-line marker, because it moves earlier and varies less with the cycle. FSH rises late in the decline, so a normal value is weak reassurance, while a clearly high one is meaningful.
Missing or chaotic periods. When cycles stop or scatter, the FSH-estradiol pair localizes the cause: ovary versus the signal from the brain. The same split covered in the results section.
Early menopause questions. For women over 45 with classic symptoms, ACOG’s guidance reflects standard practice: menopause is diagnosed by age and symptoms, not hormone levels. The measurement earns its place in the atypical cases: symptoms or stopped periods before 45, and especially before 40, where primary ovarian insufficiency is on the table. POI matters beyond fertility, affecting bone and heart health, and its workup uses repeated elevated FSH readings taken about a month apart, not a single draw. It also applies after hysterectomy or with a hormonal IUD, where there is no period signal to read.
Men with fertility concerns. After a semen analysis points to low sperm production, FSH with testosterone and LH sorts male infertility into testicular versus pituitary patterns, which have different workups and different options.
Children with early or late puberty. FSH and LH help distinguish true central puberty changes from other causes, in both girls and boys.
Suspected pituitary problems. Unexplained low FSH with low sex hormones, especially with symptoms like milky nipple discharge or vision changes, points the investigation at the pituitary, including prolactin measurement.
What results mean
The reference intervals published by UCSF’s lab guide, with the usual caveat that labs vary:
| Group | Typical FSH (mIU/mL) |
|---|---|
| Women, still menstruating | ~4.7 to 21.5 |
| Women, after menopause | ~25.8 to 134.8 |
| Men, adult | ~1.5 to 12.4 |
Reading the number is reading the thermostat:
High FSH in a woman means the pituitary is shouting because the ovaries are answering faintly. In the expected age window, that is the menopause transition or its completion. Before 40, confirmed on repeat, it raises primary ovarian insufficiency. UCSF’s guide also lists hormone therapy, certain pituitary tumors, and chromosomal conditions such as Turner syndrome among causes. In a fertility context, a high day-3 FSH predicts a weaker response to ovarian stimulation, information IVF clinics take seriously.
High FSH in a man points at the testicles: the pituitary is pushing, sperm production is not responding. Causes range from genetic conditions to prior chemotherapy, radiation, injury, or infection.
Low or inappropriately normal FSH with low sex hormones moves the problem upstream. The hypothalamus or pituitary is not sending the signal, with causes including energy deficit from underfueling or intense training, significant stress, high prolactin, and pituitary disease. “Inappropriately normal” is the subtle version: a mid-range FSH in a woman with no periods and low estradiol is itself abnormal, because a healthy pituitary would be shouting.
A normal result is the least conclusive outcome. Given monthly swings and the late-rising nature of FSH, normal does not certify fertility, does not rule out perimenopause in a symptomatic woman, and does not end a workup with ongoing symptoms. It is one coordinate, useful mainly alongside its partners.
A note on PCOS. In polycystic ovary syndrome, FSH typically sits in the normal range while LH often runs relatively high, so an elevated LH-to-FSH relationship is a suggestive pattern clinicians sometimes see. It is supporting color, not a diagnostic requirement: PCOS is diagnosed on cycle history, signs of excess androgens, and ultrasound findings, and plenty of women with PCOS show an unremarkable ratio. If irregular cycles are your issue, expect the hormone panel to be read as a set.
Two patterns, side by side
Abstract rules land better as cases, so consider two women, both 32 to 38, both with periods that stopped months ago.
The first has an FSH of 68 mIU/mL with low estradiol, repeated a month later with the same picture. The pituitary is shouting and the ovaries are not answering: this is the primary ovarian insufficiency pattern, and it triggers a defined path, confirmation, a search for causes, a plan for bone and heart protection, and a frank fertility conversation, ideally with a reproductive endocrinologist.
The second, a marathoner in a heavy training block who has also been eating less, has an FSH of 4.2 mIU/mL, squarely “normal” on the report, with low estradiol. Here the normal number is the abnormal finding: with the ovaries quiet, a healthy pituitary should be loud, so a mid-range FSH means the signal itself has been turned down. That is the hypothalamic pattern, commonly from energy deficit, and its treatment is restoring fuel and recovery, not fertility drugs.
Same symptom, same test, opposite numbers, opposite plans. This is why no FSH value, high, low, or normal, interprets itself, and why the lab report’s reassuring “in range” flag can be the most misleading line on the page.
The home FSH kit question
FSH is one of the few hormones with a true over-the-counter presence: urine “menopause check” kits sold at pharmacies, which the FDA’s home-use test guidance covers directly. They detect elevated FSH reasonably well. The problem is what an elevated reading proves, and the FDA’s own caution matches everything above: FSH rises and falls during the menopause transition and the menstrual cycle, so a single high result does not mean you are in menopause, and a single normal one does not mean you are not. A kit result also says nothing about whether contraception is still needed, a decision with obvious stakes.
Where a home FSH test can help is the same place the blood version helps: as a conversation starter, repeated over time, in someone whose period signal is hidden or absent. Where it cannot help is as a verdict, and any kit result that would change a real decision, contraception, hormone therapy, fertility plans, deserves a proper venous draw with estradiol, timed and interpreted by a clinician.
What can throw off your result
Cycle timing. The single biggest factor in menstruating women. A mid-cycle surge value read as a baseline looks alarmingly high while being completely normal. Day 2 to 4 is the convention for a reason.
Hormonal contraception. Combined pills, patches, rings, and hormonal IUDs or implants suppress FSH; that is how they work. Per MedlinePlus, birth control pills are among the medicines that affect results, and a suppressed FSH on contraception answers almost no diagnostic question. Baseline measurement belongs to a clinician-planned window off suppression; never stop contraception on your own for a lab’s sake.
Menopause hormone therapy similarly moves the axis, as UCSF notes.
Pregnancy and breastfeeding both suppress FSH. An unexpected low in someone who could be pregnant warrants a pregnancy test before theories.
High-dose biotin can interfere with the immunoassays used for FSH, as with the other hormones in this series. Stop hair-skin-nails doses at least two days before the draw and mention them.
High prolactin and significant illness or stress suppress the signal from above, part of why low results get a broader hormonal look rather than a shrug.
Fasting is not required, and time of day matters little, per MedlinePlus. The preparation that counts is the calendar and the medication list.
Cost and getting one
An FSH blood test is a routine, inexpensive draw: typically insurance-covered when ordered for a diagnosis like irregular periods or infertility, and commonly $25 to $60 self-pay through direct-to-consumer labs, with results in a day or two, as overviews like Testing.com’s FSH page describe. It is usually better bought as part of a panel, FSH with LH and estradiol, sometimes AMH and prolactin, since the pairings carry the meaning; hospital references such as Mount Sinai’s outline the same interpretive logic used here. You can compare options through August’s lab test directory.
If you are deciding whether this is even the right test for your symptoms, describing them to August, the free AI health assistant, can help you sort fatigue, cycle changes, and mood shifts into sensible next steps before you spend on labs. And to review a result with a clinician, August’s telehealth services can connect you with one.
Frequently Asked Questions
Day 2 to 4 of your cycle for a baseline, counted from the first day of full flow, usually with estradiol and often LH. Mid-cycle values run much higher as part of the ovulation surge, so an untimed draw can look abnormal while being healthy. No period calendar to count from is itself information your clinician will use.
No. Neither fasting nor time of day meaningfully moves FSH. What matters is cycle timing, an accurate list of medications including contraception and hormone therapy, and pausing high-dose biotin for a couple of days before the draw.
Postmenopausal values typically sit above roughly 25 to 30 mIU/mL, with UCSF listing 25.8 to 134.8 as the after-menopause range. But in the transition years levels swing between draws, so clinicians over 45 diagnose by symptoms and cycle history, reserving FSH for atypical cases like symptoms before 45, hysterectomy, or a hidden period signal.
Only partially, and mostly in one direction. A clearly high baseline FSH signals reduced ovarian response, which fertility clinics weigh heavily. A normal FSH proves much less, since it rises late in the decline of egg supply. AMH, with an ultrasound follicle count, has become the preferred early marker, with FSH as supporting evidence.
Because the combination locates the problem. High FSH with low estradiol points at the ovary; low or normal FSH with low estradiol points at the brain’s signal; the LH-to-FSH relationship adds texture in conditions like PCOS. Estradiol also quality-checks the FSH itself, since high early-cycle estrogen can mask an elevated FSH.
That the pituitary is pushing the testicles harder than they can answer, usually reflecting impaired sperm production from genetic causes, prior chemotherapy or radiation, injury, or infection. It is interpreted alongside testosterone, LH, and a semen analysis, which comes first in most male fertility workups.
Rarely. Hormonal contraception works by suppressing FSH and LH, so the test mostly confirms your medication is doing its job. If a true baseline matters, the measurement belongs to a clinician-planned break with alternative contraception arranged, not a mid-pack draw and never a self-directed stop.
No. Urine kits detect elevated FSH, but the FDA’s own guidance notes levels rise and fall through the transition, so single results mislead in both directions. Treat it as a data point to bring to a clinician, and do not change contraception or start hormone therapy on a kit result alone.
Loss of normal ovarian function before 40, signaled by missed periods with repeatedly elevated FSH readings taken about a month apart. It differs from early menopause in that some ovarian activity can persist, and it carries bone and cardiovascular implications that make specialist care and support important, per NICHD.
This is the question the thermostat picture answers. High FSH is the gauge, not the disease: it reflects the ovaries’ or testicles’ response, so dialing the number down without changing the underlying situation helps nothing. Estrogen-containing treatment lowers the reading by feeding back on the pituitary, which is why levels on hormone therapy are interpreted differently. The conversation that matters is about the cause and your goals, not the number.
They are sibling messengers from the pituitary with divided labor. FSH grows the follicle through the first half of the cycle; LH triggers the actual release of the egg with its mid-cycle surge, the spike ovulation predictor kits detect. In men, LH drives testosterone production while FSH drives sperm production. Workups usually measure both because their relationship carries information neither gives alone.
Less than the pill does, with a twist. Hormonal IUDs act mostly locally and many users still ovulate, so FSH itself often remains readable. What the IUD removes is the period signal: bleeding frequently stops, so you lose the usual clue for timing the draw and for judging where you are in the menopause transition. That is exactly a situation where measured FSH, interpreted carefully and sometimes repeated, earns its keep.
